Loss of FBXO7 (PARK15) results in reduced proteasome activity and models a parkinsonism‐like phenotype in mice

Mutations in the FBXO7 (PARK15) gene have been implicated in a juvenile form of parkinsonism termed parkinsonian pyramidal syndrome (PPS), characterized by Parkinsonian symptoms and pyramidal tract signs. FBXO7 (F‐box protein only 7) is a subunit of the SCF (SKP1/cullin‐1/F‐box protein) E3 ubiquitin ligase complex, but its relevance and function in neurons remain to be elucidated. Here, we report that the E3 ligase FBXO7‐SCF binds to and ubiquitinates the proteasomal subunit PSMA2. In addition, we show that FBXO7 is a proteasome‐associated protein involved in proteasome assembly. In FBXO7 knockout mice, we find reduced proteasome activity and early‐onset motor deficits together with premature death. In addition, we demonstrate that NEX (neuronal helix–loop–helix protein‐1)‐Cre‐induced deletion of the FBXO7 gene in forebrain neurons or the loss of FBXO7 in tyrosine hydroxylase (TH)‐positive neurons results in motor defects, reminiscent of the phenotype in PARK15 patients. Taken together, our study establishes a vital role for FBXO7 in neurons, which is required for proper motor control and accentuates the importance of FBXO7 in proteasome function.

[1]  A. Sali,et al.  The proteasomal subunit Rpn6 is a molecular clamp holding the core and regulatory subcomplexes together , 2011, Proceedings of the National Academy of Sciences.

[2]  H. Yokosawa,et al.  Assembly of the 26S proteasome is regulated by phosphorylation of the p45/Rpt6 ATPase subunit. , 2001, Biochemistry.

[3]  J. Lowe,et al.  Ubiquitin is a component of neurofibrillary tangles in a variety of neurodegenerative diseases , 1988, Neuroscience Letters.

[4]  W. Oyen,et al.  FBXO7 mutations cause autosomal recessive, early-onset parkinsonian-pyramidal syndrome , 2009, Neurology.

[5]  Y. Itoyama,et al.  Protection of dopaminergic neurons with a novel astrocyte modulating agent (R)-(−)-2-propyloctanoic acid (ONO-2506) in an MPTP-mouse model of Parkinson's disease , 2003, Journal of the Neurological Sciences.

[6]  J. Blesa,et al.  α-Synuclein-Independent Histopathological and Motor Deficits in Mice Lacking the Endolysosomal Parkinsonism Protein Atp13a2 , 2015, The Journal of Neuroscience.

[7]  Nicholas W Wood,et al.  The Parkinson ’ s disease – linked proteins Fbxo 7 and Parkin interact to mediate mitophagy , 2022 .

[8]  James Lowe,et al.  Depletion of 26S Proteasomes in Mouse Brain Neurons Causes Neurodegeneration and Lewy-Like Inclusions Resembling Human Pale Bodies , 2008, The Journal of Neuroscience.

[9]  孙林,et al.  Shewanella oneidensis MR-1对针铁矿的还原与汞的生物甲基化 , 2015 .

[10]  M. Hochstrasser,et al.  Molecular architecture and assembly of the eukaryotic proteasome. , 2013, Annual review of biochemistry.

[11]  P. Cortelli,et al.  A new Turkish family with homozygous FBXO7 truncating mutation and juvenile atypical parkinsonism. , 2014, Parkinsonism & related disorders.

[12]  E. Tolosa,et al.  Intranigral infusion of interleukin‐1β activates astrocytes and protects from subsequent 6‐hydroxydopamine neurotoxicity , 2003, Journal of neurochemistry.

[13]  J. Hazle,et al.  The Skp2-SCF E3 Ligase Regulates Akt Ubiquitination, Glycolysis, Herceptin Sensitivity, and Tumorigenesis , 2012, Cell.

[14]  H. Laman,et al.  Beyond ubiquitination: the atypical functions of Fbxo7 and other F-box proteins , 2013, Open Biology.

[15]  Timothy Cardozo,et al.  Systematic analysis and nomenclature of mammalian F-box proteins. , 2004, Genes & development.

[16]  A. Nicholas Levodopa‐induced hyperactivity in mice treated with 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine , 2007, Movement disorders : official journal of the Movement Disorder Society.

[17]  Timothy Cardozo,et al.  The SCF ubiquitin ligase: insights into a molecular machine , 2004, Nature Reviews Molecular Cell Biology.

[18]  Nobel C. Zong,et al.  Lysine ubiquitination and acetylation of human cardiac 20S proteasomes , 2014, Proteomics. Clinical applications.

[19]  A. Leutenegger,et al.  A new F‐box protein 7 gene mutation causing typical Parkinson's disease , 2015, Movement disorders : official journal of the Movement Disorder Society.

[20]  N. Hattori,et al.  Parkin binds the Rpn10 subunit of 26S proteasomes through its ubiquitin‐like domain , 2003, EMBO reports.

[21]  Y. Agid,et al.  A clinical, neuropsychological and olfactory evaluation of a large family with LRRK2 mutations. , 2009, Parkinsonism & related disorders.

[22]  G. Melino,et al.  DNA damage-induced ubiquitylation of proteasome controls its proteolytic activity , 2013, Oncotarget.

[23]  Steven P Gygi,et al.  A proteomics approach to understanding protein ubiquitination , 2003, Nature Biotechnology.

[24]  Heidi Phillips,et al.  Mice Lacking α-Synuclein Display Functional Deficits in the Nigrostriatal Dopamine System , 2000, Neuron.

[25]  S. Henderson,et al.  Transforming activity of Fbxo7 is mediated specifically through regulation of cyclin D/cdk6 , 2005, The EMBO journal.

[26]  David S. Park,et al.  Hypersensitivity of DJ-1-deficient mice to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrindine (MPTP) and oxidative stress. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[27]  B. Monsarrat,et al.  Affinity Purification Strategy to Capture Human Endogenous Proteasome Complexes Diversity and to Identify Proteasome-interacting Proteins*S , 2009, Molecular & Cellular Proteomics.

[28]  M. Rapé,et al.  Mechanism of Ubiquitin-Chain Formation by the Human Anaphase-Promoting Complex , 2008, Cell.

[29]  J. Crabbe,et al.  Ethanol's effects on gait dynamics in mice investigated by ventral plane videography. , 2004, Alcoholism, clinical and experimental research.

[30]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[31]  Kaya Bilgüvar,et al.  FBXO7-R498X mutation: phenotypic variability from chorea to early onset parkinsonism within a family. , 2014, Parkinsonism & related disorders.

[32]  P. Kloetzel,et al.  PI31 is a modulator of proteasome formation and antigen processing , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[33]  I. Amende,et al.  Journal of Neuroengineering and Rehabilitation Open Access Gait Dynamics in Mouse Models of Parkinson's Disease and Huntington's Disease Gait Variabilitygaitmouse Modelsneurodegenerationmovement Disordersamyotrophic Lateral Sclerosissod1 , 2022 .

[34]  S. Minoshima,et al.  Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism , 1998, Nature.

[35]  G. Lukács,et al.  Site-specific ubiquitination exposes a linear motif to promote interferon-α receptor endocytosis , 2007, The Journal of cell biology.

[36]  R. J. Kelleher,et al.  Loss of leucine-rich repeat kinase 2 causes impairment of protein degradation pathways, accumulation of α-synuclein, and apoptotic cell death in aged mice , 2010, Proceedings of the National Academy of Sciences.

[37]  Xiaohua Li,et al.  Molecular and Cellular Roles of PI31 (PSMF1) Protein in Regulation of Proteasome Function* , 2014, The Journal of Biological Chemistry.

[38]  Edward L. Huttlin,et al.  Systematic and quantitative assessment of the ubiquitin-modified proteome. , 2011, Molecular cell.

[39]  Bryan L Roth,et al.  Parkin-deficient Mice Exhibit Nigrostriatal Deficits but Not Loss of Dopaminergic Neurons* , 2003, Journal of Biological Chemistry.

[40]  Jie Shen,et al.  Loss of PINK1 causes mitochondrial functional defects and increased sensitivity to oxidative stress , 2008, Proceedings of the National Academy of Sciences.

[41]  A. Singleton,et al.  Early‐onset L‐dopa‐responsive parkinsonism with pyramidal signs due to ATP13A2, PLA2G6, FBXO7 and spatacsin mutations , 2010, Movement disorders : official journal of the Movement Disorder Society.

[42]  F. Tsai,et al.  Skp2-Mediated RagA Ubiquitination Elicits a Negative Feedback to Prevent Amino-Acid-Dependent mTORC1 Hyperactivation by Recruiting GATOR1. , 2015, Molecular cell.

[43]  M. Mann,et al.  MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification , 2008, Nature Biotechnology.

[44]  Chien-Feng Li,et al.  Skp2-dependent ubiquitination and activation of LKB1 is essential for cancer cell survival under energy stress. , 2015, Molecular cell.

[45]  Jeffrey N Keller,et al.  Proteasome Inhibition Alters Neural Mitochondrial Homeostasis and Mitochondria Turnover* , 2004, Journal of Biological Chemistry.

[46]  M. Ronaghi,et al.  Genome-wide linkage analysis of a Parkinsonian-pyramidal syndrome pedigree by 500 K SNP arrays. , 2008, American journal of human genetics.

[47]  M. Beal,et al.  Unexpected Lack of Hypersensitivity in LRRK2 Knock-Out Mice to MPTP (1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine) , 2009, The Journal of Neuroscience.

[48]  E. Morris,et al.  Molecular model of the human 26S proteasome. , 2012, Molecular cell.

[49]  B. Monsarrat,et al.  Deciphering preferential interactions within supramolecular protein complexes: the proteasome case , 2015, Molecular systems biology.

[50]  J. Murray-Rust,et al.  Structure of a Conserved Dimerization Domain within the F-box Protein Fbxo7 and the PI31 Proteasome Inhibitor* , 2008, Journal of Biological Chemistry.

[51]  B. Oostra,et al.  Loss of Nuclear Activity of the FBXO7 Protein in Patients with Parkinsonian-Pyramidal Syndrome (PARK15) , 2011, PloS one.

[52]  I. Amende,et al.  Gait dynamics in trisomic mice: quantitative neurological traits of Down syndrome , 2004, Physiology & Behavior.

[53]  M. Glickman,et al.  Reversible 26S proteasome disassembly upon mitochondrial stress. , 2014, Cell reports.

[54]  M. Mann,et al.  Andromeda: a peptide search engine integrated into the MaxQuant environment. , 2011, Journal of proteome research.

[55]  W. Kolch,et al.  On-Beads Digestion in Conjunction with Data-Dependent Mass Spectrometry: A Shortcut to Quantitative and Dynamic Interaction Proteomics , 2014, Biology.

[56]  D. Finley,et al.  Recognition and processing of ubiquitin-protein conjugates by the proteasome. , 2009, Annual review of biochemistry.

[57]  S. Elledge,et al.  Structure of the Cul1–Rbx1–Skp1–F boxSkp2 SCF ubiquitin ligase complex , 2002, Nature.

[58]  Dmitry Grapov DeviumWeb: version 0.3.2 , 2014 .

[59]  C. Sortwell,et al.  Oligodendrocyte‐type 2 astrocyte‐derived trophic factors increase survival of developing dopamine neurons through the inhibition of apoptotic cell death , 2000, The Journal of comparative neurology.

[60]  Ron Wehrens,et al.  Chemometrics with R: Multivariate Data Analysis in the Natural Sciences and Life Sciences , 2011 .

[61]  A. Ciechanover,et al.  Ubiquitin‐mediated proteolysis: biological regulation via destruction , 2000, BioEssays : news and reviews in molecular, cellular and developmental biology.

[62]  O. Levy,et al.  The neuropathology of genetic Parkinson's disease , 2012, Movement disorders : official journal of the Movement Disorder Society.

[63]  F. Förster,et al.  Unveiling the long-held secrets of the 26S proteasome. , 2013, Structure.

[64]  D. Sulzer,et al.  Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system. , 2000, Neuron.

[65]  O. Hermanson,et al.  Genetic targeting of principal neurons in neocortex and hippocampus of NEX‐Cre mice , 2006, Genesis.

[66]  T. Dawson,et al.  Bcl-x Is Required for Proper Development of the Mouse Substantia Nigra , 2005, The Journal of Neuroscience.

[67]  C. Pickart,et al.  Ubiquitin in chains. , 2000, Trends in biochemical sciences.

[68]  C. Tanner,et al.  Levodopa and the progression of Parkinson's disease. , 2004, The New England journal of medicine.

[69]  S. Vaulont,et al.  Cre-mediated germline mosaicism: a method allowing rapid generation of several alleles of a target gene. , 2000, Nucleic acids research.